Personal information

No personal information available

Activities

Collapse all

Employment (2)

Pfizer Boulder: Boulder, CO, US

2019-07-01 to present
Employment
Source: Self-asserted source
Ronald Hinklin

Array BioPharma (United States): Boulder, Colorado, US

2001-10-15 to 2019-07-01
Employment
Source: Self-asserted source
Ronald Hinklin

Education and qualifications (2)

University of Wisconsin Madison: Madison, WI, US

1996-08-15 to 2002-04-04 | Ph.D. (Chemistry)
Education
Source: Self-asserted source
Ronald Hinklin

Indiana University Bloomington: Bloomington, IN, US

1992-08-22 to 1996-05-15 | B.S.
Education
Source: Self-asserted source
Ronald Hinklin

Works (12)

A Decarboxylative Cross-Coupling Platform To Access 2-Heteroaryl Azetidines: Building Blocks with Application in Medicinal Chemistry

Organic Letters
2022-12-16 | Journal article
DOI: 10.1021/acs.orglett.2c03852
Contributors: James T. Brewster, II; Samuel D. Randall; John Kowalski; Cole Cruz; Richard Shoemaker; Eugene Tarlton; Ronald J. Hinklin
Source: check_circle
Crossref

Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity

ACS Medicinal Chemistry Letters
2018-12-13 | Journal article
DOI: 10.1021/acsmedchemlett.8b00382
Part of ISSN: 1948-5875
Part of ISSN: 1948-5875
Source: Self-asserted source
Ronald Hinklin

5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties

ACS Medicinal Chemistry Letters
2016-07-14 | Journal article
DOI: 10.1021/acsmedchemlett.6b00145
Part of ISSN: 1948-5875
Part of ISSN: 1948-5875
Source: Self-asserted source
Ronald Hinklin

Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394

ACS Medicinal Chemistry Letters
2016-07-14 | Journal article
DOI: 10.1021/acsmedchemlett.6b00140
Part of ISSN: 1948-5875
Part of ISSN: 1948-5875
Source: Self-asserted source
Ronald Hinklin

Discovery of 2-Pyridylureas as Glucokinase Activators

Journal of Medicinal Chemistry
2014-10-09 | Journal article
DOI: 10.1021/jm501204z
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Source: Self-asserted source
Ronald Hinklin

Identification of a New Class of Glucokinase Activators through Structure-Based Design

Journal of Medicinal Chemistry
2013-10-10 | Journal article
DOI: 10.1021/jm401116k
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Source: Self-asserted source
Ronald Hinklin

Structure–activity relationships of SERMs optimized for uterine antagonism and ovarian safety

Bioorganic & Medicinal Chemistry Letters
2007-07 | Journal article
DOI: 10.1016/j.bmcl.2007.04.044
Part of ISSN: 0960-894X
Source: Self-asserted source
Ronald Hinklin

A Selective Estrogen Receptor Modulator for the Treatment of Hot Flushes

Journal of Medicinal Chemistry
2006-02 | Journal article
DOI: 10.1021/jm0509795
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Source: Self-asserted source
Ronald Hinklin

A Selective Estrogen Receptor Modulator Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats

Journal of Medicinal Chemistry
2005-11 | Journal article
DOI: 10.1021/jm050723z
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Source: Self-asserted source
Ronald Hinklin

Stereoselective N-Glycosylation by Staudinger Ligation

Organic Letters
2004-11 | Journal article
DOI: 10.1021/ol048271s
Part of ISSN: 1523-7060
Part of ISSN: 1523-7052
Source: Self-asserted source
Ronald Hinklin

p-Methoxybenzyl Ether Cleavage by Polymer-Supported Sulfonamides

Organic Letters
2002-04 | Journal article
DOI: 10.1021/ol025514c
Part of ISSN: 1523-7060
Part of ISSN: 1523-7052
Source: Self-asserted source
Ronald Hinklin

Glycosyl Sulfonylcarbamates:  New Glycosyl Donors with Tunable Reactivity

Journal of the American Chemical Society
2001-04 | Journal article
DOI: 10.1021/ja005735i
Part of ISSN: 0002-7863
Part of ISSN: 1520-5126
Source: Self-asserted source
Ronald Hinklin

Peer review (4 reviews for 1 publication/grant)

Review activity for Journal of medicinal chemistry. (4)
How many people are using ORCID?